Skip to main content
Premium Trial:

Request an Annual Quote

IntegraGen, IFCT to Evaluate microRNA as Lung Cancer Biomarker

NEW YORK (GenomeWeb) – Molecular diagnostics firm IntegraGen announced that it is collaborating with the French Intergroup of Thoracic Oncology (IFCT), a network of lung cancer specialists, to investigate the potential of a specific microRNA as a biomarker for advanced non-small cell lung cancer.

Specifically, the partners will examine whether the expression of the miRNA, miR-31-3p, is correlated with patient outcomes associated with epidermal growth factor receptor (EGFR)-targeted therapies for lepidic adenocarcinomas of the lung.

Should this effort be successful, IntegraGen and IFCT may expand their alliance to include other types of lung cancer, the company said.

IntegraGen has previously reported data showing that miR-31-3p signatures can be used to predict outcomes associated with anti-EGFR therapies in metastatic colorectal cancer. By collaborating with IFCT, the firm hopes to demonstrate the miRNA's utility as a biomarker for other cancers.

"This study will enable us to explore a biomarker which is potentially capable of guiding treatment in patients with lung cancer, identifying who will benefit most from therapies and potentially allowing us to avoid unnecessary and expensive chemotherapy options," Jacques Cadranel, a member of the IFCT scientific council, said in a statement.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.